論文・技術情報追加のお知らせ

①Posterior Reversible Encephalopathy Syndrome Onset Within 24 Hours Following Moderna mRNA Booster COVID-19 Vaccination: Vaccine Adverse Event Vs. Hypertension?

COVID-19ワクチン接種後24時間以内に発症した後可逆性脳症症候群

対象DB：VAERS

②Latent class analysis of patients' background factors affecting the risk of specific adverse drug reactions to dipeptidyl peptidase 4 inhibitors.

DPP-4阻害剤特異的副作用リスクに影響する患者背景因子のLatent Class解析

対象DB：JADER

③European Safety Analysis of mRNA and Viral Vector COVID-19 Vaccines on Glucose Metabolism Events.

COVID-19ワクチンのグルコース代謝イベントに関する安全性解析

対象DB：EudraVigilance

④Eosinophilia Induced by Blocking the IL-4/IL-13 Pathway: Potential Mechanisms and Clinical Outcomes.

IL-4/IL-13経路遮断による誘発される好酸球増多の安全性解析

対象DB：EudraVigilance

⑤Evaluation of Preoperative Risk Factors for Sugammadex-Induced Anaphylaxis: Analysis of the Japanese Adverse Drug Event Report Database.

スガマデクスによるアナフィラキシーの術前危険因子の評価

対象DB：JADER